Compared with inhibin B and AFC, AMH was more consistently correlated with the clinical degree of follicle pool depletion in young women presenting with elevated FSH levels. AMH may provide a more accurate assessment of the follicle pool in young hypergonadotropic patients, especially in the clinically challenging subgroups of patients with elevated FSH and regular menses (i.e. IOF) and in hypergonadotropic women with cycle disturbances not fulfilling the POF diagnostic criteria (i.e. TOF).
BACKGROUND The risk of recurrent oncological disease due to the reintroduction of cancer cells via autotransplantation of cryopreserved ovarian tissue is unknown. METHODS A systematic review of literature derived from MEDLINE, EMBASE and the Cochrane Library was conducted. Studies on follow-up after autotransplantation; detection of cancer cells in ovarian tissue from oncological patients by histology, polymerase chain reaction or xenotransplantation; and epidemiological data on ovarian metastases were included. RESULTS A total of 289 studies were included. Metastases were repeatedly detected in ovarian tissue obtained for cryopreservation purposes from patients with leukaemia, as well as in one patient with Ewing sarcoma. No metastases were detected in ovarian tissue from lymphoma and breast cancer patients who had their ovarian tissue cryopreserved. Clinical studies indicated that one should be concerned about autotransplantation safety in patients with colorectal, gastric and endometrial cancer. For patients with low-stage cervical carcinoma, clinical data were relatively reassuring, but studies focused on the detection of metastases were scarce. Oncological recurrence has been described in one survivor of cervical cancer and one survivor of breast cancer who had their ovarian tissue autotransplanted, although these recurrences may not be related to the transplantation. CONCLUSIONS It is advisable to refrain from ovarian tissue autotransplantation in survivors of leukaemia. With survivors of all other malignancies, current knowledge regarding the safety of autotransplantation should be discussed. The most reassuring data regarding autotransplantation safety were found for lymphoma patients.
PurposeOncofertility focuses on providing fertility and endocrine-sparing options to
patients who undergo life-preserving but gonadotoxic cancer treatment. The
resources needed to meet patient demand often are fragmented along
disciplinary lines. We quantify assets and gaps in oncofertility care on a
global scale.MethodsSurvey-based questionnaires were provided to 191 members of the Oncofertility
Consortium Global Partners Network, a National Institutes of
Health–funded organization. Responses were analyzed to measure trends
and regional subtleties about patient oncofertility experiences and to
analyze barriers to care at sites that provide oncofertility services.ResultsSixty-three responses were received (response rate, 25%), and 40 were
analyzed from oncofertility centers in 28 countries. Thirty of 40 survey
results (75%) showed that formal referral processes and psychological care
are provided to patients at the majority of sites. Fourteen of 23
respondents (61%) stated that some fertility preservation services are not
offered because of cultural and legal barriers. The growth of oncofertility
and its capacity to improve the lives of cancer survivors around the globe
relies on concentrated efforts to increase awareness, promote collaboration,
share best practices, and advocate for research funding.ConclusionThis survey reveals global and regional successes and challenges and provides
insight into what is needed to advance the field and make the discussion of
fertility preservation and endocrine health a standard component of the
cancer treatment plan. As the field of oncofertility continues to develop
around the globe, regular assessment of both international and regional
barriers to quality care must continue to guide process improvements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.